Related by context. Frequent words. (Click for all words.) 63 Inc Therapeutic Competitors 62 Drug Shows Promise 62 Anti Infectives 61 Receives Orphan Drug Designation 61 Initiates Phase II 61 Cardiovascular Monitoring 60 gets USFDA nod 60 Antifungal 60 Inflammatory Diseases 60 Monoclonal Antibodies 60 Small Molecule 60 FDA Clears 60 Meets Primary Endpoint 60 Recombinant Human 60 Bioavailability 60 immunodiagnostics 60 Atopic Dermatitis 59 Bioequivalence 59 Announces FDA Clearance 59 Bio Pharmaceutical 59 Report companiesandmarkets.com adds 59 Influenza Vaccine 59 Connetics Corporation 58 Develop Novel 58 High Growth Forecasted 58 Diagnostic Tests 58 Dyslipidemia 58 Patent Issued 58 Drug Candidate 58 Biosimilar 58 Nobilon 58 Therapeutic Competitors 58 MultiCell Technologies 58 Monoclonal Antibody 58 Gastric Cancer 58 Biotest AG 58 Presents Positive 58 Exploit collaboration 57 Idera Pharmaceuticals 57 Genetic Testing 57 Drug Resistant 57 Significantly Improves 57 Completes Enrollment 57 Masimo SET Signal Extraction 57 Pipeline Analysis 57 China Aoxing Pharmaceutical 57 Teijin Pharma 57 Radiopharmaceuticals 57 Diabetic Neuropathy 57 Single Dose 57 Hepatitis C Virus 57 RNAi Therapeutics 57 Int J 57 Quark Pharmaceuticals 57 Hepatocellular Carcinoma 57 Pulmonary Arterial Hypertension 56 Benign Prostatic Hyperplasia 56 Kyowa Hakko Kogyo 56 Cholesterol Drug 56 www.vivus.com 56 MorphoSys AG FSE MOR 56 Reduces Risk 56 Licensing Agreements 56 Vitro Diagnostics 56 Receives FDA Clearance 56 Thrombin 56 Eculizumab 56 Transcept Pharmaceuticals 56 Influenza Virus 56 Proprietary Products 56 Xianling Gubao 56 Medtronic Spinal 56 J Am Acad 56 Drug Metabolism 56 Pharmaceutical 56 Allergic Rhinitis 55 Report Analyzes 55 Flow Cytometry 55 Patient Enrollment 55 Elan Pharma 55 Improves Survival 55 Biopharma 55 Files Shelf Registration Statement 55 Omni Bio 55 Immunoglobulin 55 BioPharmaceuticals 55 Agios Pharmaceuticals 55 Vicuron Pharmaceuticals 55 CureDM 55 Reportlinker Adds Global 55 Antipsychotic 55 DAIICHI SANKYO 55 commercialize phytocannabinoid based 55 THALOMID 55 R sorafenib tablets 55 Vitro Diagnostic 55 FDA Accepts 55 Holds Promise 55 Barrier Therapeutics Inc. 55 EntreMed Inc. 55 Phase III Clinical Trial